معرفی
Susan Charman is a Professor and Director of the Centre for Drug Candidate Optimisation at Monash University's Monash Institute of Pharmaceutical Sciences. Her research focuses on ADME-informed drug candidate optimisation, particularly for neglected and tropical infectious diseases. She leads projects targeting malaria, schistosomiasis, and other parasitic infections, with a strong emphasis on translating basic discoveries into clinical candidates.
Research Interests:
- Drug Discovery and Development
- Drug Metabolism and Pharmacokinetics
- Antimalarial and Antischistosomal Agents
- Pharmaceutical Sciences
Recent Projects (Selected):
- Discovery of New Antimalarials with Novel Mechanisms (2025–2027)
- MedChem Australia: Drug Discovery Collaboration (2023–2028)
- Development of FPR1 Biased Agonists for Myocardial Infarction (2023–2025)
Grants and Collaborations:
Charman leads and collaborates on projects funded by organizations like the Medicines for Malaria Venture (MMV) and the Australian National Health and Medical Research Council. Her work contributes to UN Sustainable Development Goals, particularly Goal 3 (Good Health and Well-being) and Goal 3.3 (Combat communicable diseases).
Labs and Teams:
She oversees the Centre for Drug Candidate Optimisation (CDCO), a facility dedicated to advancing drug candidates through preclinical stages. The CDCO collaborates with academic and industry partners globally.
